OMEROS CORPORATION

Lobbying client · Washington · filed 2025 to 2025

Biopharmaceutical company

$80,000 Reported spend

1 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 1 filing. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (165820), not by name.

Firms hired 1

AVENUE SOLUTIONS $80,000 1 filing

Bills named in these filings 2

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025

1 filing
S 891
Bipartisan Health Care Act

1 filing

Reported by year 1 year

2025 $80,000 1 filing

Issues lobbied 2

Budget/Appropriations 1
Health Issues 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 1

SENATE 1

Recent filings 2 total

1T

AVENUE SOLUTIONS

1st Quarter (Jan 1 - Mar 31) 2025 · Senate · $80,000 income · posted Jul 21, 2025

View → Q1

AVENUE SOLUTIONS Amended

1st Quarter (Jan 1 - Mar 31) 2025 · Senate · $80,000 income · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.